CRI-ONE Firm Rebuttal Series - Evaluation Edition

In stock
SKU
crione-rebuttal-evaluation
Special Price $1,250.00 Regular Price $5,000.00
75% off list

Why you'd want it

Check who owns what before you buy: the dated ownership and priority record for every CRI-ONE product.

  • Who it's for: buyers, counsel and investors doing due diligence on any of the 139 CRI-ONE products.
  • The problem it solves: one place to review ownership, first art, filing, market dates and copyright for each product.
  • What you get: a 991-page Word document with per-product records and registers, for evaluation only; no blueprint licence.

The ownership and priority record for all 139 CRI-ONE products: proprietary ownership, first art, first to file, first to market and copyright, each tied to dated sources, with the USPTO, copyright, deposition and prior-art registers. Patent pending - U.S. Application No. 19/835,210. Evaluation use only; no blueprint license.

Explore the store

Before you buy a design, you want to know whose it is, how long it has been theirs, and what stands behind that. This edition answers those questions for every product in the catalog, one firm record at a time. Each record starts from the earliest dated disclosure - the 2017 printed book Invent Depositions, the master IP register, the Internet Archive captures of crioner.com (2010), cri-one.com (2011) and buyinvent.com (2014) - and walks forward through the USPTO filings, the store listings and the copyright registrations, with every evidence file fingerprinted by SHA-256.

Valuation

Pre-production blueprint usage right, patent pending, non-exclusive. The analog this product is closest to in the market is specialized research-grade blueprint; the closest commercial analog depends on buyer field-of-use.

Patent landscape

Patent-pending; defensible in method and composition claims where the architecture is novel.

Market opportunity

  • Addressable buyer universe sized against the research/early-production tier for the applicable field.

Comparable transactions

  • Non-exclusive research-grade blueprint licenses: typically $500K–$5M per field-of-use license in SEC-reported comparables.

Estimated valuation range

Realistic clearing band for a non-exclusive blueprint usage right: $500K (research / single-buyer evaluation) → $5M (strategic non-exclusive with manufacturing / deployment rights).

Listed catalog price: $10,000 — public anchor for direct enquiry; actual clearing price negotiated inside the range above with the buyer, scope (non-exclusive, territory, field-of-use), and milestone structure.

Description

What you receive

  • The Firm Rebuttal Series, Evaluation Edition: a 991-page Word document with the portfolio record, the 9 October 2026 update for U.S. Application 19/835,210, and one record for each of the 139 products.
  • Nine sections in every record: the record in brief, proprietary ownership, first art, first to file, first to market, copyright, firm rebuttals to the common challenges, an evidence index, and a ready notice line.
  • The registers behind it: USPTO filings, 20 U.S. Copyright Office registrations (newest: TX 9-642-452, CGB Mathematical Depositions Complete 2026, effective 15 March 2026) and the books, first-to-market dates, deposition anchors and prior-art references.

Terms

When you buy, you buy the use of this evaluation edition only. It is for your own evaluation of CRI-ONE products and their ownership and priority record. No license to any blueprint, design, code, drawing or invention is granted. The mutual NDA at cri-one.com/nda/ applies.

© 2017-2026 Christopher Gabriel Brown (CRI-ONE). All rights reserved. Patent pending - U.S. Application No. 19/835,210.

Write Your Own Review
You're reviewing:CRI-ONE Firm Rebuttal Series - Evaluation Edition
We found other products you might like!
© 2026 Christopher Gabriel Brown (CRI-ONE), cri-one.com